Chlamydia trachomatis (CT); Neisseria gonorrhoeae (NG); and Trichomonas vaginalis
Based on the patient's age and on ACOG Practice Guidelines for cervical cancer screening and Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis screening
Liquid Cytology (PreservCyt®) Preservative (ThinPrep®) collected in a ThinPrep® vial
30 days Ambient (transport)
Refrigerated and frozen=unacceptable
Refer to Interpretive Report
Patients 21-25: If the Pap result is ASC-US then the HPV mRNA assay will be performed at an additional charge (CPT code(s): 87624). Chlamydia trachomatis (CT)/ Neisseria gonorrhoeae (NG) RNA, TMA (CPT code(s): 87491, 87591), and Trichomonas vaginalis ("trich" or TV), Qualitative TMA, Pap Vial (CPT code(s): 87661) will also be performed.
Patients 26-29: If the Pap result is ASC-US then the HPV mRNA assay will be performed at an additional charge (CPT code(s): 87624). CT/NG RNA, TMA (CPT code(s): 87491, 87591), and TV, Qualitative TMA, Pap Vial (CPT code(s): 87661) will also be performed.
Patients 30-65: If the Pap result is negative and the HPV mRNA screen (CPT code(s): 87624) is positive (detected), then HPV mRNA Genotypes 16, 18/45 will be performed at an additional charge (CPT code(s): 87625). CT/NG RNA, TMA (CPT code(s): 87491, 87591), and TV, Qualitative TMA, Pap Vial (CPT code(s): 87661) will also be performed.
Pap results requiring physician interpretation will be performed at an additional charge (CPT Code(s): 88141; HCPCS: G0124).
Based on the patient's age and on ACOG Practice Guidelines for cervical cancer screening and Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis screening
5 to 7 days
88175 (R - 87624, 87491, 87591, 87625, 87661)
